PATENT CLAIM ANALYSIS

Application Number: 16151860
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "056000"]

Abstract:
Compositions and methods for preventing thrombogenesis can include antithrombin and heparin. In one example, a conjugate of antithrombin and heparin where at least 50 wt % of the heparin is conjugated to antithrombin can be present. Furthermore, in one example, at least 98 wt % of the heparin in the composition has a molecular weight greater than 3,000 Daltons.

Claim (Index 18):
The composition of  claim 13 , wherein at least 99 wt % of the heparin in the composition has a molecular weight greater than 3,000 Daltons and less than 30,000 Daltons.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.58537
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10101568', '14018840', '12739287', '14111300', '10251097']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7421906200349386
- 35 USC 102 Novelty (BERT): 0.4889875648592237
- Combined Prediction Score: 0.7168703145173672
- Mean Citation Score: 141.40386719999995
- Max Citation Score: 187.96686
- Similarity Product: 131.19268097607852

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test